AIM ImmunoTech Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
AIM ImmunoTech Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • AIM ImmunoTech Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $700K, a 10.4% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $700K -$81K -10.4% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $763K -$29K -3.66% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $697K -$132K -15.9% Dec 31, 2023 10-Q 2024-08-14
Q3 2023 $727K -$139K -16.1% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $781K -$108K -12.1% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $792K +$648K +450% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $829K +$680K +456% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $866K +$722K +501% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $889K +$732K +466% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $144K -$24K -14.3% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $149K -$30K -16.8% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $144K -$44K -23.4% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $157K +$27K +20.8% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $168K +$27K +19.1% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $179K +$27K +17.8% Dec 31, 2020 10-K 2022-03-31
Q3 2020 $188K +$26K +16% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $130K -$43K -24.9% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 $141K +$4K +2.92% Mar 31, 2020 10-Q/A 2020-05-14
Q4 2019 $152K Dec 31, 2019 10-K 2021-03-31
Q3 2019 $162K Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $173K Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $137K Mar 31, 2019 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.